Recro Pharma, Inc. (REPH) Reaches $7.96 Formed H&S; Peoples Bancorp Inc. (PEBO) Had 0 Bulls

Among 6 analysts covering Peoples Bancorp Inc (NASDAQ:PEBO), 0 have Buy rating, 0 Sell and 6 Hold. Therefore 0 are positive. Peoples Bancorp Inc had 11 analyst reports since July 28, 2015 according to SRatingsIntel. Raymond James downgraded the stock to “Mkt Perform” rating in Friday, December 16 report. Wood maintained it with “Market Perform” rating and $22 target in Monday, March 7 report. The stock of Peoples Bancorp Inc. (NASDAQ:PEBO) earned “Hold” rating by Sandler O’Neill on Tuesday, January 23. Keefe Bruyette & Woods maintained it with “Hold” rating and $3400 target in Tuesday, July 25 report. The stock has “Outperform” rating by Raymond James on Friday, October 30. The company was maintained on Thursday, December 21 by Keefe Bruyette & Woods. The stock of Peoples Bancorp Inc. (NASDAQ:PEBO) has “Hold” rating given on Wednesday, July 26 by Boenning & Scattergood. The firm has “Market Perform” rating given on Friday, October 30 by Keefe Bruyette & Woods. The rating was maintained by Keefe Bruyette & Woods on Tuesday, October 3 with “Hold”. See Peoples Bancorp Inc. (NASDAQ:PEBO) latest ratings:

23/01/2018 Broker: Sandler O’Neill Rating: Hold New Target: $37.0 Maintain
21/12/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $40.0 Maintain
03/10/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $34.0 Maintain

Recro Pharma, Inc. (REPH) formed H&S with $7.40 target or 7.00% below today’s $7.96 share price. Recro Pharma, Inc. (REPH) has $152.25 million valuation. It closed at $7.96 lastly. It is down 26.61% since February 7, 2017 and is uptrending. It has outperformed by 9.91% the S&P500.

Investors sentiment decreased to 1.65 in 2017 Q3. Its down 0.56, from 2.21 in 2017Q2. It is negative, as 7 investors sold Recro Pharma, Inc. shares while 10 reduced holdings. 5 funds opened positions while 23 raised stakes. 9.63 million shares or 4.72% less from 10.10 million shares in 2017Q2 were reported. Commercial Bank Of America Corporation De holds 0% or 55,745 shares in its portfolio. Dimensional Fund Ltd Partnership accumulated 129,560 shares. Moreover, Tiaa Cref Invest Limited Liability Corporation has 0% invested in Recro Pharma, Inc. (NASDAQ:REPH). Jpmorgan Chase & reported 21,784 shares stake. Cadence Cap Management Ltd Llc holds 0.09% or 167,637 shares in its portfolio. Rhumbline Advisers reported 0% in Recro Pharma, Inc. (NASDAQ:REPH). Janney Montgomery Scott Limited Liability Corporation accumulated 16,485 shares or 0% of the stock. Moreover, Parametric Limited Liability Com has 0% invested in Recro Pharma, Inc. (NASDAQ:REPH) for 16,428 shares. Strs Ohio holds 0% or 4,000 shares in its portfolio. Kingdon Mngmt Lc invested in 0.15% or 259,948 shares. Bank & Trust Of Mellon Corporation reported 52,391 shares or 0% of all its holdings. Tower Research Capital Limited Liability Company (Trc) holds 0% or 2,895 shares. Broadfin Cap Ltd Liability Corporation holds 4.12% of its portfolio in Recro Pharma, Inc. (NASDAQ:REPH) for 3.10 million shares. 1,308 are owned by Royal Bancorporation Of Canada. Jacobs Levy Equity Mgmt holds 0.01% or 33,164 shares.

Analysts await Recro Pharma, Inc. (NASDAQ:REPH) to report earnings on March, 5. They expect $-0.78 earnings per share, up 3.70% or $0.03 from last year’s $-0.81 per share. After $-0.48 actual earnings per share reported by Recro Pharma, Inc. for the previous quarter, Wall Street now forecasts 62.50% negative EPS growth.

Since December 12, 2017, it had 0 insider purchases, and 5 selling transactions for $1.43 million activity. Shares for $115,139 were sold by SCP Vitalife Partners (Israel) II – L.P.. On Thursday, January 4 SCP Vitalife Partners II LP sold $41,822 worth of Recro Pharma, Inc. (NASDAQ:REPH) or 4,732 shares. 93,237 shares were sold by Broadfin Healthcare Master Fund Ltd, worth $919,128 on Tuesday, December 12.

Among 8 analysts covering Recro Pharma (NASDAQ:REPH), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Recro Pharma had 14 analyst reports since August 25, 2015 according to SRatingsIntel. The firm has “Buy” rating by Janney Capital given on Monday, August 29. Piper Jaffray maintained Recro Pharma, Inc. (NASDAQ:REPH) rating on Tuesday, July 25. Piper Jaffray has “Buy” rating and $1100 target. Roth Capital maintained the shares of REPH in report on Monday, July 31 with “Buy” rating. The company was initiated on Friday, September 16 by Roth Capital. The rating was initiated by H.C. Wainwright with “Buy” on Wednesday, September 2. The stock has “Hold” rating by Zacks on Tuesday, August 25. As per Thursday, July 20, the company rating was maintained by Roth Capital. The rating was initiated by Piper Jaffray with “Overweight” on Monday, December 19. The company was initiated on Friday, September 16 by TH Capital. Roth Capital maintained Recro Pharma, Inc. (NASDAQ:REPH) rating on Thursday, November 9. Roth Capital has “Buy” rating and $18.0 target.

Investors sentiment decreased to 1.22 in 2017 Q3. Its down 0.43, from 1.65 in 2017Q2. It turned negative, as 6 investors sold Peoples Bancorp Inc. shares while 31 reduced holdings. 10 funds opened positions while 35 raised stakes. 10.36 million shares or 1.67% more from 10.18 million shares in 2017Q2 were reported. Citigroup owns 6,378 shares. Ameritas Invest Partners invested in 0% or 1,418 shares. Citadel Limited Co reported 0% of its portfolio in Peoples Bancorp Inc. (NASDAQ:PEBO). 1,400 are owned by New York State Teachers Retirement Sys. Tower Rech Cap Llc (Trc) reported 0% stake. 145 are held by Glenmede Na. Aperio Ltd Limited Liability Company holds 24,442 shares. California State Teachers Retirement Systems holds 0% or 26,190 shares in its portfolio. New York State Common Retirement Fund holds 18,800 shares or 0% of its portfolio. 12,654 were accumulated by Voya Management Ltd Liability Company. Great West Life Assurance Can has invested 0% of its portfolio in Peoples Bancorp Inc. (NASDAQ:PEBO). Cornercap Counsel has 42,565 shares. Virginia Retirement Et Al, a Virginia-based fund reported 8,100 shares. Bank Of America De accumulated 46,690 shares. Strs Ohio invested in 22,700 shares.

The stock increased 0.32% or $0.11 during the last trading session, reaching $34.22. About 86,922 shares traded or 150.03% up from the average. Peoples Bancorp Inc. (NASDAQ:PEBO) has risen 47.34% since February 7, 2017 and is uptrending. It has outperformed by 30.64% the S&P500.